AIDS Healthcare Foundation
19
3
5
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.5% vs industry average
5%
1 trials in Phase 3/4
17%
2 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Cefixime Clinical Trial
Role: collaborator
Intervention for Virologic Suppression in Youth
Role: collaborator
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
Role: collaborator
Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
Role: collaborator
Epividian / AHF: Positive Pathways - HIV Retention in Care
Role: collaborator
Cabenuva Injection Tracking in CHORUS
Role: collaborator
Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
Role: collaborator
Quantitative and Qualitative Research for "mHealth Program to Support People Living With HIV Across the HIV Care Continuum"
Role: collaborator
Hepatitis C Screening Alerts
Role: collaborator
Hepatitis C Diagnosis to Treatment Management
Role: collaborator
COVID-19 Quantitative Antibody Titers & Booster Vaccinations
Role: collaborator
Cefixime for Alternative Syphilis Treatment
Role: collaborator
Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables
Role: collaborator
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Role: lead
Specimen Repository for HIV Immunopathogenesis
Role: lead
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Role: lead
Test and Treat TB: A Proof of Concept Trial in South Africa
Role: collaborator
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Role: collaborator
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Role: collaborator
All 19 trials loaded